BIOVIC-B.ST(BIOVIC-B.ST)
BIOVIC-B.ST
No analyst ratings available
No analyst price targets available for BIOVIC-B.ST
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $26M | $46M | $98M |
| Low | $26M | $46M | $98M |
| High | $26M | $46M | $98M |
| EBITDA Avg | $-26M | $-46M | $-98M |
| Low | $-26M | $-46M | $-98M |
| High | $-26M | $-46M | $-98M |
| EBIT Avg | $-26M | $-46M | $-98M |
| Low | $-26M | $-46M | $-98M |
| High | $-26M | $-46M | $-98M |
| Net Income Avg | $-47M | $-23M | $4M |
| Low | $-47M | $-23M | $4M |
| High | $-47M | $-23M | $4M |
| EPS Avg | $-0.20 | $-0.10 | $0.02 |
| Low | $-0.20 | $-0.10 | $0.02 |
| High | $-0.20 | $-0.10 | $0.02 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |